The Science and Practice of Treating Patients with Opioid Use Disorder AK SUMMIT-5 substance_use_disorders__pregnancy_complicated_by_a_chronic_disease_-_candy_stockton,_md,

5 substance_use_disorders__pregnancy_complicated_by_a_chronic_disease_-_candy_stockton,_md,_fasam (1080p)

Video Transcription

Video Summary

Dr. Candy Stockton, an addiction specialist, recounts her initiation of buprenorphine therapy for pregnant patients in rural Northern California due to limited access to methadone clinics. She highlights the challenges faced by pregnant individuals with substance use disorders in obtaining treatment and stresses addressing underlying factors affecting their ability to stay in treatment. Dr. Stockton challenges stigmas surrounding addiction during pregnancy and advocates for evidence-based care to improve outcomes for mothers and babies. She emphasizes the importance of combating biases hindering effective treatment and stresses the need for compassionate and evidence-based care for pregnant individuals with substance use disorders. Furthermore, the speaker discusses considerations for a baby's future in cases of maternal substance use disorder, including supporting families and stabilizing them instead of immediate removal of children. Treatment strategies for opioid and stimulant use disorders during pregnancy are outlined, along with advocating for patient rights and ethically aligning interventions for optimal care of mothers and infants.

Keywords

Dr. Candy Stockton

addiction specialist

buprenorphine therapy

pregnant patients

rural Northern California

methadone clinics

substance use disorders

treatment challenges

stigmas surrounding addiction

evidence-based care

mothers and babies outcomes

biases in treatment

compassionate care

maternal substance use disorder

treatment strategies